The rat Toxo1 locus directs toxoplasmosis outcome and controls parasite proliferation and spreading by macrophage-dependent mechanisms.

Toxoplasmosis is a healthcare problem in pregnant women and immunocompromised patients. Like humans, rats usually develop a subclinical chronic infection. LEW rats exhibit total resistance to Toxoplasma gondii infection, which is expressed in a dominant mode. A genome-wide search carried out in a cohort of F(2) progeny of susceptible BN and resistant LEW rats led to identify on chromosome 10 a major locus of control, which we called Toxo1. Using reciprocal BN and LEW lines congenic for chromosome 10 genomic regions from the other strain, Toxo1 was found to govern the issue of T. gondii infection whatever the remaining genome. Analyzes of rats characterized by genomic recombination within Toxo1, reduced the interval down to a 1.7-cM region syntenic to human 17p13. In vitro studies showed that the Toxo1-mediated refractoriness to T. gondii infection is associated with the ability of the macrophage to impede the proliferation of the parasite within the parasitophorous vacuole. In contrast, proliferation was observed in fibroblasts whatever the genomic origin of Toxo1. Furthermore, ex vivo studies indicate that macrophage controls parasitic infection spreading by a Toxo1-mediated mechanism. This forward genetics approach should ultimately unravel a major pathway of innate resistance to toxoplasmosis and possibly to other apicomplexan parasitic diseases.

[1]  P. Bastien,et al.  Innate Refractoriness of the Lewis Rat to Toxoplasmosis Is a Dominant Trait That Is Intrinsic to Bone Marrow-Derived Cells , 2005, Infection and Immunity.

[2]  J. Aliberti Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma GONDII , 2005, Nature Reviews Immunology.

[3]  L. Sibley Intracellular Parasite Invasion Strategies , 2004, Science.

[4]  A. Sher,et al.  Evasion of innate immunity by parasitic protozoa , 2002, Nature Immunology.

[5]  J. Casanova,et al.  Forward genetics of infectious diseases: immunological impact. , 2002, Trends in immunology.

[6]  Ron Korstanje,et al.  From QTL to gene: the harvest begins , 2002, Nature Genetics.

[7]  V. Carruthers Host cell invasion by the opportunistic pathogen Toxoplasma gondii. , 2002, Acta tropica.

[8]  Jennifer J. Johnson,et al.  Genetic analysis of influences on survival following Toxoplasma gondii infection. , 2002, International journal for parasitology.

[9]  L. Sibley,et al.  Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii. , 2002, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[10]  I. Bernard,et al.  Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type‐2 and type‐1 immune‐mediated diseases , 2001, Immunological reviews.

[11]  P. Gros,et al.  Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions. , 2001, Trends in microbiology.

[12]  D. Gauguier,et al.  Rat chromosome 9 bears a major susceptibility locus for IgE response , 2000, European journal of immunology.

[13]  F. Roberts,et al.  HLA-class II genes modify outcome of Toxoplasma gondii infection. , 1999, International journal for parasitology.

[14]  L. Sibley,et al.  Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafficking pathways. , 1999, Experimental parasitology.

[15]  P. Sutton,et al.  Different manifestations of Toxoplasma gondii infection in F344 and LEW rats , 1999, Medical Microbiology and Immunology.

[16]  J. K. Frenkel,et al.  Toxoplasmosis of rats: a review, with considerations of their value as an animal model and their possible role in epidemiology. , 1998, Veterinary parasitology.

[17]  D. Buxton,et al.  Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. , 1998, Veterinary research.

[18]  L. Sibley,et al.  Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanism of entry. , 1997, Journal of immunology.

[19]  E. Wakeland,et al.  Speed congenics: a classic technique in the fast lane (relatively speaking). , 1997, Immunology today.

[20]  J. Todd,et al.  Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1. , 1997, Journal of immunology.

[21]  F. Fang Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. , 1997, The Journal of clinical investigation.

[22]  F. Fang Mechanisms of nitric oxide-related antimicrobial activity , 1997 .

[23]  Steven M. Wolinsky,et al.  The role of a mutant CCR5 allele in HIV–1 transmission and disease progression , 1996, Nature Medicine.

[24]  J. Zimmerberg,et al.  Toxoplasma invasion: the parasitophorous vacuole is formed from host cell plasma membrane and pinches off via a fission pore. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[26]  C. Tournamille,et al.  Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy–negative individuals , 1995, Nature Genetics.

[27]  L. Sibley,et al.  Invasion of Toxoplasma gondii occurs by active penetration of the host cell. , 1995, Journal of cell science.

[28]  P. Ossorio,et al.  Structure and Function of the Parasitophorous Vacuole Membrane Surrounding Toxoplasma gondii , 1994, Annals of the New York Academy of Sciences.

[29]  B. Pipy,et al.  Eicosanoid production by mouse peritoneal macrophages during Toxoplasma gondii penetration: role of parasite and host cell phospholipases , 1993, Infection and immunity.

[30]  R. McLeod,et al.  Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A x B/B x A recombinant inbred and B10 congenic mice. , 1989, Journal of immunology.

[31]  J. Remington,et al.  Mechanisms of killing of Toxoplasma gondii by rat peritoneal macrophages , 1986, Infection and immunity.

[32]  J. Couvreur,et al.  Congenital toxoplasmosis in twins: a series of 14 pairs of twins: absence of infection in one twin in two pairs. , 1976, The Journal of pediatrics.

[33]  W. de Souza,et al.  Toxoplasma gondii partially inhibits nitric oxide production of activated murine macrophages. , 2002, Experimental parasitology.

[34]  Anne E Kwitek,et al.  Multifactorial genetics: Rat genetics: attachign physiology and pharmacology to the genome , 2002, Nature Reviews Genetics.

[35]  J. Dubremetz,et al.  Potential of β-galactosidase-expressing Toxoplasma gondii for in situ localization and observation of rare stages of the parasite life cycle , 2001, Parasitology Research.

[36]  A. Hill,et al.  The immunogenetics of human infectious diseases. , 1998, Annual review of immunology.